# Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer

> **NCT01188187** · PHASE3 · COMPLETED · sponsor: **Achieve Life Sciences** · enrollment: 1022 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Custirsen
- **DRUG:** Docetaxel
- **DRUG:** Prednisone
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT01188187
- **Lead sponsor:** Achieve Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2014-02
- **Final completion:** 2014-06
- **Target enrollment:** 1022 (ACTUAL)
- **Last updated:** 2016-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01188187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01188187, "Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01188187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*